REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanghai Micurx Pharmaceutical Co., Ltd. Profile Updated: December 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Shanghai MicuRx Pharmaceutical Co., Ltd. is a biopharmaceutical company focusing on novel therapeutics for infectious diseases. The company is dedicated to creating treatments for patients with infections caused by multidrug-resistant super bacteria, and also has a pipeline of other investigational medicines for cancer and inflammation. The company was established in 2012 and is headquartered in Shanghai City, China.

Headquarters
Building 101, 2, 1-4 Floor, No. 53 Edison Road, China (Shanghai) Pilot Free Trade Zone, Shanghai
Shanghai; Shanghai; Postal Code: 201210

Contact Details: Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.

Website: http://micurxchina.com

Basic Information
Total Employees:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.
Registered Capital:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.
Incorporation Date:
August 07, 2012
Key Executives
Purchase this report to view the information.
SECRETARY
Ownership Details
Purchase this report to view the information.
10.92%
Purchase this report to view the information.
10.8%
Purchase this report to view the information.
10.49%
Purchase this report to view the information.
5.89%
Purchase this report to view the information.
3.47%
Subsidiaries
Corecase (Beijing) Pharmaceutical Co., Ltd.
Mengke Pharmaceutical Technology (Shanghai) Co., Ltd.
Micurx Pharmaceuticals, Inc.
Company Performance
Financial values in the chart are available after Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
6.58%▲
Total operating revenue
0.59%▲
Operating profit (EBIT)
32.34%▲
Net Profit (Loss) for the Period
33.56%▲
Total assets
-25.12%▼
Total equity
-54.63%▼
Operating Profit Margin (ROS)
106.72%▲
Net Profit Margin
112.45%▲
Return on Equity (ROE)
-23.82%▼
Debt to Equity Ratio
18.93%▲
Quick Ratio
-4.28%▼
Cash Ratio
-0.65%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Wuhan Yzy Biopharma Co. Ltd.
 
Shenzhen Guohua Network Security Technology Co., Ltd.
Jiangsu Gdk Biological Technology Co., Ltd
 
CANbridge Pharmaceuticals Inc. (Hong Kong) (北海康成制药有限公司 (香港))
Zhaoke Ophthalmology Limited (Hong Kong) (兆科眼科有限公司 (香港))
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo